GGrantIndex
← Leaderboards

Rakesh Kumar

University Of Texas Md Anderson Can Ctr

Google Scholar ↗PubMed ↗ORCID ↗
$9,172,951
Attributed
$9,172,951
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY2005–07
$2M$1.5M$1M$500K$0
'05
'06
'07

Funding mix

By agency

NIH$9,172,951 · 7

By mechanism

R01$9,172,951 · 6
P50$0 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Breast Neoplasms”

Research focus

Breast NeoplasmsNeoplasm /Cancer InvasivenessNeoplastic ProcessLaboratory MouseMetastasisHeregulinCell MigrationCell ProliferationEnzyme ActivityGrowth Factor ReceptorsGenetically Modified AnimalsEpidermal Growth FactorBiological Signal TransductionMammary GlandNeoplastic CellMetalloendopeptidasesEstrogen ReceptorsNeoplasm /Cancer GeneticsPhenotypeMonoclonal AntibodyCell Cell InteractionEnzyme Induction /RepressionAntireceptor AntibodyScid Mouse

Grant awards (36)

SERM Regulation of PAK Pathway in Endometrial Cancer$293,511
R01 · FY2007 · CA · contact PI
Pak1 - PIN Pathway in Breast Cancer Progression$257,716
R01 · FY2007 · CA · contact PI
HER2 Pathway in Breast Cancer Progression and Treatment$250,558
R01 · FY2007 · CA · contact PI
Pak1 and Hormone Response in Breast Cancer Progression$244,809
R01 · FY2007 · CA · contact PI
SERM Regulation of PAK Pathway in Endometrial Cancer$302,276
R01 · FY2006 · CA · contact PI
Pak1 - PIN Pathway in Breast Cancer Progression$265,413
R01 · FY2006 · CA · contact PI
Role of Metastatic Tumor Antigen-1 in Mammary Gland$262,464
R01 · FY2006 · CA · contact PI
HER2 Pathway in Breast Cancer Progression and Treatment$258,041
R01 · FY2006 · CA · contact PI
Pak 1 and Hormone Response in Breast Cancer Progression$252,120
R01 · FY2006 · CA · contact PI
SERM Regulation of PAK Pathway in Endometrial Cancer$309,550
R01 · FY2005 · CA
Pak1 - PIN Pathway in Breast Cancer Progression$271,800
R01 · FY2005 · CA
Role of Metastatic Tumor Antigen-1 in Mammary Gland$268,780
R01 · FY2005 · CA
HER2 Pathway in Breast Cancer Progression and Treatment$264,250
R01 · FY2005 · CA
Pak1 and Hormone Response in Breast Cancer Progression$258,188
R01 · FY2005 · CA
SERM Regulation of PAK Pathway in Endometrial Cancer$309,550
R01 · FY2004 · CA
Pak1 in Mammary Gland Development and Carcinogenesis$274,500
R01 · FY2004 · CA
Pak1 - PIN Pathway in Breast Cancer Progression$271,800
R01 · FY2004 · CA
Role of Metastatic Tumor Antigen-1 in Mammary Gland$268,780
R01 · FY2004 · CA
HER2 Pathway in Breast Cancer Progression and Treatment$264,250
R01 · FY2004 · CA
Targeting Urokinase Pathway for Breast Cancer Therapy$311,250
R01 · FY2003 · CA
Pak1 in Mammary Gland Development and Carcinogenesis$289,500
R01 · FY2003 · CA
HER2 Pathway in Breast Cancer Progression and Treatment$279,250
R01 · FY2003 · CA
Role of Metastatic Tumor Antigen-1 in Mammary Gland$268,780
R01 · FY2003 · CA
HEREGULIN AND BREAST CANCER PROGRESSION$251,512
R01 · FY2003 · CA
Pak1 in Mammary Gland Development and Carcinogenesis$351,750
R01 · FY2002 · CA
Targeting Urokinase Pathway for Breast Cancer Therapy$311,250
R01 · FY2002 · CA
HEREGULIN AND BREAST CANCER PROGRESSION$244,185
R01 · FY2002 · CA
RECEPTOR BLOCKADE FOR BREAST CANCER$212,934
R01 · FY2002 · CA
Targeting EGFR for chemoprevention of head/neck cancer$0
P50 · FY2002 · CA
Targeting Urokinase Pathway for Breast Cancer Therapy$311,250
R01 · FY2001 · CA
Pak1 in Mammary Gland Development and Carcinogenesis$274,500
R01 · FY2001 · CA
HEREGULIN AND BREAST CANCER PROGRESSION$237,075
R01 · FY2001 · CA
RECEPTOR BLOCKADE FOR BREAST CANCER$206,731
R01 · FY2001 · CA
Pak1 in Mammary Gland Development and Carcinogenesis$43,750
R01 · FY2001 · CA
HEREGULIN AND BREAST CANCER PROGRESSION$230,166
R01 · FY2000 · CA
RECEPTOR BLOCKADE FOR BREAST CANCER$200,712
R01 · FY2000 · CA